The intracellular events and specifically the role of protein kinase C-mediated protein phosphorylation, after a-adrenergic receptor stimulation of the heart, are not well understood. We examined the phosphorylation of sarcolemmal, sarcoplasmic reticular, myofibrillar, and cytosolic proteins in perfused beating rabbit hearts on activation of protein kinase C by phenylephrine. Perfusion of rabbit hearts with phenylephrine was associated with a positive inotropic response, which was dose and time dependent.
Stimulation of the heart by either a-or /3-adrenergic agonists is associated with increases in the force of contraction, although there are qualitative differences in the mechanical responses to these agents. /3-Adrenergic activation shortens both the time to peak tension and the relaxation time and increases contractility and chronotropy. ca-Adrenergic stimulation prolongs the time to peak tension, causes a slow and small increase in contractility, and does not affect relaxation or chronotropy.'
The intracellular events after P-adrenergic stimulation have been well characterized, and the mechanism of action appears to involve increases in cAMP levels and cAMP-dependent phosphorylation of key regulatory proteins.2 However, the cellular mechanisms underlying a-adrenergic stimulation in the heart are not well understood, and it is not presently clear whether protein phosphorylation may be involved. a-Adrenergic stimulation occurs without increases in myocardial cAMP levels,3 but it is accompanied by increases in the activity of phospholipase C.45 The mechanism by which this enzyme is activated during receptor-agonist binding is thought to involve protein-protein coupling through a guanine nucleotide-binding regulatory protein. 6 Phospholipase C catalyzes the hydrolysis of phosphatidylinositol 4,5 -diphosphate, with the resultant formation of myo-inositol 1,4,5-trisphosphate (IP3) and 1,2-diacylglycerol. 1P3 has been shown to mediate the release of Ca`+ from intracellular Ca2`stores in various tissues, although it is still controversial whether 1P3 can mobilize Ca21 from the sarcoplasmic reticulum (SR) in the myocardium.7,8 Recently, inositol trisphosphate and tetrakisphosphate have been reported to increase the sensitivity of the contractile proteins to calcium in porcine cardiac muscle fibers.9 Increased calcium sensitivity of the contractile proteins was also observed during a-adrenergic stimulation of rabbit hearts.10 1,2-Diacylglycerol, the other derivative of phosphatidylinositol 4,5-diphosphate hydrolysis, which may act as the physiological activator of the Ca2-activated, phospholipid-dependent protein kinase (protein kinase C), was also reported to increase during a-adrenergic stimulation in the mammalian heart.'1 However, there is relatively little information available on the activation and the functional significance of protein kinase C in intact hearts. In one study, cultured neonatal rat heart myocytes were treated with the a-adrenergic agonist norepinephrine, and this was found to be associated with activation or translocation of protein kinase C from the cytosolic to the membranous fraction.'2 Activation of protein kinase C may result in phosphorylation of key intracellular proteins, which may be linked to the inotropic response of the heart to a-adrenergic agonists. However, the role of protein kinase C in mediating the positive inotropic response of cardiac muscle to a-adrenergic stimulation presently appears controversial. 13, 14 In vitro studies have shown that several cardiac proteins may serve as substrates for protein kinase C. These include phospholamban"5 in the SR, a 15 -kd protein16 in sarcolemma, a 28-kd protein17 in the cytosol, and C protein,18 troponin I, and troponin T19 in the myofibrils. Actually troponin I and troponin T have each been reported to possess at least two phosphorylation sites for protein kinase C. ,uM phenylephrine for 4 minutes was associated with a decrease in the coronary flow of the perfused heart (control, 41 +±1.5 ml/min; phenylephrine, 36.5+±1.5 ml/ min); perfusion with 0.1 ,uM isoproterenol for 3 minutes was associated with an increase in the coronary flow of the perfused heart (control, 41 ± 1.5 ml/min; isoproterenol, 48±4 ml/min). These changes in the coronary flow became significant after 2 minutes of infusion with either drug, and at that time the infusion rate was decreased by 10% in the case of phenylephrine, whereas it was increased by 15% in the case of isoproterenol. At the peak of the positive inotropic response to these agonists, the hearts were freeze-clamped with precooled (-196°C (20 ul) from each reaction mixture was spotted on P81 ion exchange chromatography paper, the spotted paper was washed four times with 75 mM phosphoric acid, and the radioactivity was determined by liquid scintillation counting. Protein kinase C activity represents the difference in kinase activity obtained in the presence of 1 ,uM Ca2' alone and the activity obtained in the presence of 1 ,uM Ca2+, 5 g.g phosphatidylserine, and 1 ,uM phorbol 12-myristate 13-acetate.
Preparation and Gel Electrophoresis of Membranous, Myofibrillar, and Cytosolic Proteins
Microsomes were prepared as previously described.21 Myofibrils were prepared from the pellet of the first centrifugation of the heart homogenates as we previously described. 24 The supernatant (30 ml) obtained during the first high-spin centrifugation in the preparation of microsomes was used for the isolation of cytosolic proteins. Proteins were precipitated by addition of solid ammonium sulfate to the supernatant. The saturated ammonium sulfate solution was centrifuged at 20,000g for 20 minutes. The pellet was resolubilized in 1.5 ml inhibiting buffer containing (mM) Na2HPO4 30, NaF 15, and EDTA 6 (pH 7.0) and desalted on a Bio-Gel P-6DG desalting column (Bio-Rad). The final recovered volume of the concentrated cytosol was 4.5 ml, representing 6.6- 
Preparation of Inositol Trisphosphates
Inositol phosphates were extracted from freezeclamped and powdered heart tissue with 0.5 M trichloroacetic acid27 and washed with 20 vol water-saturated diethyl ether. The final fraction was directly applied onto a Dowex-1 column (formate form) and eluted with formic acid-ammonium formate buffers. 28 The fraction containing the inositol trisphosphates, as identified by the comigration of [3H]1P3 standard applied to the column, was free from different sugar monophosphates and bisphosphates, but it was heavily contaminated with [32P]-labeled ATP. The final purification was performed by electrophoretic separation. The effluent from the Dowex-1 column, containing the inositol trisphosphates, was mixed with a slurry of an equal amount of Dowex-50 resin. After centrifugation, an aliquot from the supernatant was directly spotted on cellulose thin-layer sheets and electrophoretically separated using 0.06 M sodium oxalate buffer (pH 1.5). Three distinct radioactive spots were obtained, and they were clearly separated from each other. One was identified as ATP, by applying This procedure did not allow separation of 1P3 from other inositol trisphosphate isomers; therefore, the results reflect the combined radioactivity of inositol trisphosphate isomers. After electrophoresis, the plates were dried and placed in contact with Kodak X-Omat films. The identified spot corresponding to the inositol trisphosphate fraction was cut and counted for radioactivity. The recovery of inositol trisphosphate extraction (85%) was monitored by including [3H]-labeled standards.
Other Procedures
The specific activity of [y-32P]ATP in the perfused hearts was determined by the method described by Kopp and Barany.29 Specific radioactivities (mean±SEM) were 6.6±0.5 cpm/pmol ATP (n=8) for controls, 6.1±0.3 cpm/ pmol ATP (n =6) for phenylephrine-treated hearts, 6.0±0.2 cpm/pmol ATP (n=3) for prazosin-treated hearts, and 6.1±0.3 cpn/pmol ATP (n=4) for isoproterenoltreated hearts.
Protein concentration was determined either by the Lowry30 or the amido black31 method for the samples used for the protein kinase C assay or polyacrylamide gels, respectively, using bovine serum albumin as a standard. Results are expressed as mean±SEM. Statistical analysis was carried out using Student's t test for unpaired observations. Values ofp<0.05 were regarded as statistically significant.
Results
Beating rabbit hearts were perfused with various concentrations of phenylephrine (0.5, 1. ,uM), and the hemodynamic responses were examined.
Phenylephrine had a time-and dose-dependent positive effect on left ventricular inotropy (+dP/dt). In these whole-heart preparations, there was no negative effect on contractility observed (Figure 1 ), which was previously reported in rat papillary muscle. 32 The positive inotropic effect reached its maximum value at 4 minutes, and the optimal concentration of phenylephrine was 10 ,M ( Figure 2 ). Higher concentrations (> 10 ,M) of phenylephrine did not result in any further increase in contractility (data not shown). There was no effect on relaxation (-dP/dt) or on chronotropy observed ( Table  1) . Preperfusion of hearts with 0.1 ,uM prazosin, a specific a1-adrenergic antagonist, resulted in complete blockade of the increase in inotropy mediated by phenylephrine ( Figure 3 and Table 1 ). Thus, the stimulatory effects on contractility (Figure 2 ) appeared to be mediated specifically by a,-adrenergic receptors. In control experiments, rabbit hearts were perfused with isoproterenol, a ,B-adrenergic agonist; this resulted in increases in inotropy higher than those observed in the presence of phenylephrine (Figure 3 ) as well as increases in relaxation and changes in chronotropy (Table  1) , in agreement with previous observations.1 "10 It has been previously shown that the effects of a,-adrenergic agonists in various tissues are associated with activation of phospholipase C and increases in 1P3 levels. Thus, we examined whether stimulation of intact beating hearts by phenylephrine was also associated with increased 32P-labeling of inositol trisphosphates.
We observed that stimulation with 10 ,uM phenylephrine for 4 minutes resulted in significantly higher levels of 32p labeling of IP3s (13.6+1.1 nmol 32p/g wet tissue, n=4) compared with control hearts (10.2+0.8 nmol 32P/g wet tissue, n=5). Furthermore, this increase in the labeling of 1P3 could be blocked by 0.1 ,uM prazosin (9.8+0.6 nmol 32P/g wet tissue, n=3).
Increases in 1P3 levels of cardiac cells suggested an increase in diacylglycerol levels, which is thought to be the physiological activator of protein kinase C. To examine whether a,-adrenergic stimulation of intact hearts was associated with activation of protein kinase C, rabbit hearts were perfused for 4 minutes with 10 ,M phenylephrine, under which conditions the maximal inotropic response was observed. Control hearts were treated under identical conditions but in the absence of phenylephrine. The cytosolic and sarcolemmal proteinenriched membranous fractions of control and phenylephrine-treated hearts were isolated, and the activity levels of protein kinase C, present in these fractions, were determined. We observed a considerable translocation of protein kinase C activity from the cytosolic to the membranous fraction in the agonist-treated hearts compared with the control hearts (Table 2) . Prazosin, the a,-adrenergic antagonist, which attenuated the inotropic response of the hearts to phenylephrine, blocked the translocation of protein kinase C (Table 2) .
In vitro studies have shown that protein kinase C may phosphorylate several proteins in the mammalian myocardium. These proteins include a 15-kd protein in sarcolemma,16 phospholamban in SR,15 troponin I,19 troponin T,19 and C protein18 in the myofibrils, and a 28-kd cytosolic protein. '7 To determine whether these proteins may also be phosphorylated by protein kinase C in vivo, during a-adrenergic stimulation, rabbit hearts were perfused with phenylephrine (10 4uM), and at the peak of the positive inotropic response (4 minutes), when there was translocation of protein kinase C activity observed (Table 2) , we examined the levels of 32P incorporation into membranous, myofibrillar, and cytosolic proteins. Isoproterenol was included as a positive control in these studies, since the effect of this agonist Perfusion with isoproterenol was also associated with increased phosphorylation of the 15-kd sarcolemmal protein in rabbit hearts (Table 3 ), in agreement with previous studies in rat21 and guinea pig hearts.33 Examination of 32p incorporation into phospholamban in SR revealed that there were no increases in the phenylephrine-treated hearts (Table 3) . However, in rabbit hearts perfused with isoproterenol, there was increased (2.8-fold) phosphorylation of phospholamban (Table 3) , which was blocked by propranolol (data not shown). In vitro studies have also shown that troponin I, troponin T, and C protein in the myofibrils may be phosphorylated by protein kinase C. However, it is not presently known whether these proteins may also be phosphorylated in vivo. Thus, we examined the degree of phosphorylation of the myofibrillar proteins on activation of protein kinase C by phenylephrine in the intact hearts. There were no observed increases in the`2P 16,483+724 Values are mean± SEM of n hearts. Perfused rabbit hearts were stimulated with 10 yM phenylephrine in the absence or presence of 0.1 ,M prazosin for 4 minutes and then freeze-clamped. Preparation of membranous and cytosolic fractions and assays of protein kinase C activity were carried out as described under "Materials and Methods." The protein kinase specific activities obtained in the membranous vs. the cytosolic fractions of control hearts were as follows:
252±23 vs. 261±20 pmol 32P/mg protein/min in the absence of Ca'2, phosphatidylserine, and phorbol 12-myristate 13-acetate (these activity values were not significantly different when assayed in the presence of either phosphatidylserine or phorbol 12-myristate 13-acetate alone) and 363±34 vs. 400±44 pmol "2P/mg protein/min in the presence of Ca2' alone. Phenylephrine stimulation of the perfused hearts was not associated with any significant increases in the protein kinase activity associated with either the membranous or the cytosolic fractions, assayed as outlined above.
Protein kinase C activity in this table represents the difference in kinase activities obtained in the presence of Ca'2 alone and those obtained in the presence of Ca'+, phosphatidylserine, and phorbol 12-myristate 13-acetate. Membranous and cytosolic total enzyme activities are expressed as picomoles "2p per gram heart tissue per minute. The total protein kinase C activities present in both membranes and cytosol of the perfused hearts were as follows:
16,159±585 pmol "P/g heart tissue/min for control hearts, 16,953±874 pmol "2P/g heart tissue/min for phenylephrinetreated hearts, and 16,909±758 pmol "2P/g heart tissue/min for prazosin-treated hearts. Origin incorporation into any of the myofibrillar proteins (Figure 5 ) in the phenylephrine-treated hearts compared with control hearts ( Figure 5 and Table 3 ). In parallel experiments, stimulation of rabbit hearts with the fl-adrenergic agonist isoproterenol was associated with significant increases in the degree of phosphorylation of troponin I and C protein ( Table 3) . Examination of protein phosphorylation in the cytosolic fraction revealed that a-adrenergic stimulation of rabbit hearts was associated with a small but significant increase in the 32P incorporation of a 28-kd protein (Table 3) . Preperfusion of the hearts with prazosin. which reversed the effect of phenylephrine on contractility, prevented the increased phosphorylation of the 28-kd cytosolic
of the cytosolic fraction from the isoproterenol-stimulated beating rabbit hearts revealed no apparent increases in the 32P incorporation into the 28-kd protein ( Myofibrillar proteins were isolated and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography, as described in "Materials and Methods. " The phosphorylated protein bands are identified as follows: TnT, troponin T; TnI, troponin I; LC, light chains. Orthophosphate (P,) incorporation was determined as described in Figure 4 . Pi incorporation (picomoles P,per milligram protein loaded onto the gel lane) was as follows: 61 (C), 66 (P), 64 (Pr), and 72 (I) for TnT; and 77 (C), 73 (P), 76 (Pr), and 219 (I) for TnL agonists in beating rabbit hearts or by phorbol esters in guinea pig hearts. 17 Stimulation of either rabbit or guinea pig'7 hearts with isoproterenol did not result in any increases in the phosphorylation of this cytosolic protein. The increases in the phosphorylation of the 15-kd and the 28-kd proteins were observed in the presence of propranolol and atropine, suggesting that they were not mediated through f-receptor or muscarinic receptor stimulation. Furthermore, these increases were prevented in the presence of prazosin.
Several studies have shown that ac-adrenergic stimulation of various tissues is associated with activation of phospholipase C and increases in the hydrolysis of phosphatidylinositol phosphates, leading to the formation of inositol trisphosphates34 and diacylglycerol. 1 Both of these molecules may act as second messengers mediating the effects of a-adrenergic agonists. In this study we have also observed increases in the P, labeling of inositol trisphosphates during a-adrenergic stimulation of the beating rabbit hearts. However, the physiological role of increases in inositol trisphosphates in the Cytosolic proteins were isolated and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography, as described in "Materials and Methods." The phosphorylated protein band (28kDa) was identified by its mobility relative to pure protein standards. Orthophosphate (P,) incorporation was determined as described in Figure 4 . P1 incorporation (picomoles P, per milligram protein loaded onto the gel lane) was as follows: 73 (C) and 101 (Phe) pmol Pi/mg protein.
heart is not well understood presently. Studies have reported that inositol trisphosphates may be active7 or inactives in releasing calcium from the SR. Thus, increases in inositol trisphosphate may not be a critical factor in increasing the cytosolic calcium concentration in the heart that is due to a-adrenergic stimulation. Inositol trisphosphates have been also shown to enhance the calcium sensitivity of the myofibrils in porcine cardiac muscle fibers,9 although this was not true in saponin-skinned bundles of guinea pig ventricles.7 Thus, if 1P3 could directly influence the sensitivity of myofibrils to calcium, this might be one of the mechanisms mediating the increased contractility in a-stimulated hearts.
Increases in diacylglycerol by a-agonists may lead to activation of protein kinase C and phosphorylation of regulatory proteins in the myocardium. In this study, we present the first evidence on activation of protein kinase C by a-agonists in an intact, beating heart preparation. Activation of protein kinase C was associated with translocation of part of the cytosolic enzyme to the sarcolemma and increased phosphorylation of the 15- 15 -kd protein was shown to be phosphorylated mainly by a Ca2-dependent protein kinase in isolated canine cardiac sarcolemma. The lack of phosphorylation of phospholamban in SR and of the myofibrillar proteins may suggest that these proteins were not accessible to the activated protein kinase C in vivo. However, we also observed increases in the phosphorylation of a 28-kd cytosolic protein upon a-adrenergic stimulation of the hearts. This finding is in agreement with a previous study, in which protein kinase C was activated by phorbol esters or diacylglycerol analogues in intact guinea pig hearts.17 However, the increased phosphorylation of the 28-kd cytosolic protein on activation of protein kinase C in either rabbit or guinea pig hearts was associated with a decrease in the specific activity of the cytosolic enzyme, indicating that other more complex pathways may be involved in the phosphorylation of this protein in vivo. It is also possible that other low abundance proteins may get phosphorylated upon activation of protein kinase C by phenylephrine in vivo, but they were not detectable by the techniques used in this study.
The lack of phosphorylation of phospholamban in SR and of the myofibrillar proteins, upon a-adrenergic stimulation, may explain the differences observed in the cardiac contractile responses between a-and ,B-adrenergic agonists. Phosphorylation of phospholamban by increases in cAMP levels, mediated by 13-adrenergic agents, is associated with increases in the SR Ca21 uptake rates and, thus, regulation of the relaxation phase (-dP/dt) of contraction. Furthermore, phosphorylation of troponin I, which also occurs during ,B-adrenergic stimulation of the heart, is associated with decreased sensitivity of the myofibrils, leading to regulation of the relaxation phase as well. However, this phase is not changed during a-adrenergic stimulation of the heart, consistent with the lack of phosphorylation of phospholamban and troponin I. Increases in the phosphorylation of phospholamban by cAMP-dependent protein kinase and increases in the SR Ca21 uptake would also lead to increased Ca2' accumulated by the SR, which would be available to be released for subsequent contractions. This would lead to shortening of the time to peak tension, which is not changed during a-adrenergic stimulation. Thus, these differences in the substrate specificities of protein kinase C and cAMPdependent protein kinase may at least partially explain the differences in the nature of the cardiac contractile responses to a-and ,B-adrenergic agents.
It is well known that a-adrenergic agents are associated with coronary vasoconstriction, whereas ,B-adrenergic agents are associated with coronary vasodilation. However, both agonists are associated with increases in the contractility of the intact heart. These increases in contractility may involve some common phosphoproteins as well as some different mechanisms. A common phosphoprotein is the 15-kd sarcolemmal protein, which has been implicated in increases in the slow inward Ca21 current21 and, thus, increases in contractility. A 28-kd cytosolic protein was also found to be phosphorylated upon a-adrenergic stimulation of beating hearts, whereas this protein was not phosphorylated upon ,3-adrenergic stimulation. However, it becomes difficult to link increases in the phosphorylation of this protein to the positive inotropic response to a-agonists, since the 28-kd protein was also found to be phosphorylated in hearts perfused with phorbol esters, which produced a negative inotropic effect.'7 Another mechanism involved in mediating the positive inotropic response of the heart to a-adrenergic agonists may be the increased sensitivity of the myofibrils to Ca2+. However, the changes in the Ca 2 sensitivity of the myofilaments upon activation of protein kinase C by a-adrenergic agonists or phorbol esters are not presently well understood. Stimulation of rabbit papillary muscles by a-adrenergic agonists was reported to be associated with increased Ca'+ sensitivity of the myofibrils,10 whereas activation of protein kinase C by 12-deoxyphorbol 13 isobutyrate 20 acetate in human trabeculae carneae was associated with a decrease in the responsiveness of the myofibrils to calcium. 23 The decreased sensitivity was suggested to reflect phosphorylation of thin-filament regulatory proteins by protein kinase C.23 However, in the present study we examined the phosphorylation of thin filaments upon activation of protein kinase C by phenylephrine, and we did not detect any changes in the phosphorylation of either troponin I or troponin T. Furthermore, a recent report by Capogrossi et a136 suggested that activation of protein kinase C by phorbol esters or dioctanoylglycerol is not associated with decreased myofilament responsiveness to calcium in adult rat cardiac myocytes. The increased sensitivity of the myofibrils, observed by a-adrenergic agonists,9 may be due to increases in 1P3 (discussed above) or increases in the intracellular pH, caused by phosphorylation of the Na-H exchange system by protein kinase C.37 This would result in extrusion of H' ions from the cell and an intracellular alkalization. Increases in the intracellular pH would lead to increases in the sensitivity of the myofibrils and the positive inotropic effect of a-adrenergic agents.
In summary, our data demonstrate for the first time the activation of protein kinase C in an intact beating heart preparation upon a-adrenergic stimulation. Activation of protein kinase C was associated with increased phosphorylation of a 15-kd membrane protein and a 28-kd cytosolic protein. However, there were no increases in the phosphorylation of phospholamban in SR and of troponin I, troponin T, and C protein in the myofibrils, all of which are substrates for protein kinase C in vitro. In parallel studies, activation of cAMPdependent protein kinase by ,B-adrenergic stimulation was associated with increased phosphorylation of the 15-kd sarcolemmal protein, phospholamban, troponin I, and C protein. The differences in these substrate proteins, in response to increases in the second messengers cAMP and diacylglycerol, may be responsible for the differences in the contractile responses of the myocardium to ,3-and a-adrenergic stimulation.
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